Core Points - IMCD N.V. announces the nomination of Mr. Janus Smalbraak for reappointment as Chair of the Supervisory Board at the 2026 AGM, along with Mr. Stephan Nanninga for a third term and Mr. Willem Eelman for a second term [1][2][3][4] Group 1: Nominations and Terms - Janus Smalbraak has been nominated for a fourth and final term of two years as Chair of the Supervisory Board, having first been appointed in 2016 [2] - Stephan Nanninga is nominated for a third term of two years, having first been appointed in 2018 [3] - Willem Eelman is nominated for a second term of four years, having first been appointed in 2022 [4] Group 2: Purpose and Future Plans - The reappointments aim to maintain continuity and leverage accumulated knowledge within the Supervisory Board to support IMCD's management in the coming years [5] - The Supervisory Board intends to expand its composition with a sixth member in 2026, with a search currently ongoing [5] Group 3: Company Overview - IMCD, based in Rotterdam, is a leading global partner in the distribution and formulation of specialty chemicals and ingredients, focusing on sustainable value in the supply chain [6] - In 2024, IMCD reported revenues of EUR 4,728 million and employed over 5,100 staff [7]

Core Viewpoint - IMCD N.V. has received improved ESG ratings from ISS ESG and Sustainalytics, reflecting its ongoing progress in environmental, social, and governance areas [1][3][4]. Group 1: ESG Ratings Improvement - IMCD's ISS ESG rating has been upgraded to B- from C+, positioning the company above the industry average [3]. - Sustainalytics has lowered IMCD's ESG Risk Rating from 12.6 to 11.6, maintaining its status in the "low risk" category [4]. Group 2: Recognition and Achievements - Earlier in 2025, IMCD received the EcoVadis Platinum medal, placing it in the top 1% of organizations assessed worldwide for sustainability performance [2]. - The upgrades in ratings are attributed to strong management of ESG-related risks, transparency in disclosures, and responsible business practices [3][4]. Group 3: Company Overview - IMCD, based in Rotterdam, is a leading global partner for the distribution and formulation of specialty chemicals and ingredients, focusing on sustainable value in the supply chain [6]. - In 2024, IMCD reported revenues of EUR 4,728 million and has over 5,100 employees [7].

Core Insights - IMCD N.V. has announced the acquisition of 100% of the shares in Apus Química SpA, enhancing its position in the specialty chemicals market [1][3] - Apus Química, founded in 2016, specializes in performance chemicals for the rubber, plastics, and chemical sectors, generating approximately EUR 15 million in revenue in 2024 [2][5] - The acquisition is expected to close in July 2025, subject to customary closing conditions [3] Company Overview - IMCD is a leading global partner for the distribution and formulation of specialty chemicals and ingredients, headquartered in Rotterdam, the Netherlands [4] - In 2024, IMCD reported revenues of EUR 4,728 million and has over 5,100 employees [5] - IMCD's shares are traded on Euronext Amsterdam and are included in the Dutch ESG AEX index, reflecting strong ESG practices [5] Apus Química Overview - Apus Química is based in Santiago, Chile, and focuses on distributing a broad portfolio of specialty chemicals for the advanced materials industry [2][5] - The company operates with four employees and two warehouses, serving the Chilean market [2]